Predicting end-stage renal disease after liver transplant

American Journal of Transplantation

Volumn 13, Issue 7, 2013, Pages 1782-1792

  Israni, A K ^a,b,c   Xiong, H ^b   Liu, J ^b   Salkowski, N ^b   Trotter, J F ^d   Snyder, J J ^b,c   Kasiske, B L ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

End stage renal disease; liver transplantation; registry analysis; risk prediction

Indexed keywords

BILIRUBIN; CREATININE; SERUM ALBUMIN;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CADAVER DONOR; CALIBRATION; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MEDICAL HISTORY; NEOPLASM; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; RACE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; SURGICAL RISK;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; UNITED STATES;

EID: 84879553890     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12257     Document Type: Article

References (27)

1. Sharma P, Schaubel DE, Guidinger MK, et al. Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant 2011; 11: 2372-2378.
2. Sharma P, Welch K, Eikstadt R, et al. Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl 2009; 15: 1142-1148.
3. Gonwa TA, McBride MA, Mai ML, Wadei HM., Kidney transplantation after previous liver transplantation: Analysis of the organ procurement transplant network database. Transplantation 2011; 92: 31-35.
4. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
5. Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment. Transplantation 2001; 72: 1934-1939.
6. Leithead JA, Tariciotti L, Gunson B, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant 2012; 12: 965-975.
7. de Boccardo G, Kim JY, Schiano TD, et al. The burden of chronic kidney disease in long-term liver transplant recipients. Transplant Proc 2008; 40: 1498-1503.
8. Lamattina JC, Foley DP, Mezrich JD, et al. Chronic kidney disease stage progression in liver transplant recipients. Clin J Am Soc Nephrol 2011; 6: 1851-1857.
9. Zand MS, Orloff MS, Abt P, et al. High mortality in orthotopic liver transplant recipients who require hemodialysis. Clin Transplant 2011; 25: 213-221.
10. Gentleman R., S original by Kenneth Hess and R port by R. Gentleman (2010). muhaz: Hazard Function Estimation in Survival Analysis. R package version 1.2.5. http://CRAN.R-project.org/package=muhaz. Accessed April 9, 2013.
11. Eilers P, Marx B., Flexible smoothing with B-splines and penalties. Stat Sci 1996; 11: 89-121.
12. Hurvich CM, Simonoff JS., Tsai Chih-Ling: Smoothing parameter selection in nonparametric regression using an improved Akaike information criterion. JRSSB 1998; 60: 271-293.
13. Hoeting JA, Madigan D, Raftery AE, Volinsky CT., Bayesian model averaging: A tutorial. Stat Sci 1999; 14: 382-417.
14. Kass RE, Raftery AE., Bayes factors. J Amer Statistical Assoc 1995; 90: 773-795.
15. Raftery AE., Model selection in social research. Sociol Methodol 1995; 25: 111-163.
16. Therneau T., A package for survival analysis in S. 2.36-14. 2012.
17. Raftery AE, Hoeting JA, Volinsky CT, Painter I, Yeung KY., Bayesian Model Averaging. R Package Version 3.15.1". 2012. 2-23-2013. Available at: http://CRAN.R-project.org/package=BMA. Accessed February 22, 2013.
18. Gonwa TA, Klintmalm GB, Levy M, et al. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59: 361-365.
19. Sanchez EQ, Melton LB, Chinnakotla S, et al. Predicting renal failure after liver transplantation from measured glomerular filtration rate: Review of up to 15 years of follow-up. Transplantation 2010; 89: 232-235.
20. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
21. Akkina SK, Asrani SK, Peng Y, et al. Development of organ-specific donor risk indices. Liver Transpl 2012; 18: 395-404.
22. Leithead JA, Ferguson JW, Bates CM, et al. Chronic kidney disease after liver transplantation for acute liver failure is not associated with perioperative renal dysfunction. Am J Transplant 2011; 11: 1905-1915.
23. Paramesh AS, Roayaie S, Doan Y, et al. Post-liver transplant acute renal failure: Factors predicting development of end-stage renal disease. Clin Transplant 2004; 18: 94-99.
24. Gerhardt T, Terjung B, Knipper P, et al. Renal impairment after liver transplantation-A pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation. Eur J Med Res 2009; 14: 210-215.
25. Eason JD, Gonwa TA, Davis CL, et al. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant 2008; 8: 2243-2251.
26. Smith JM, Biggins SW, Haselby DG, et al. Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant 2012; 12: 3191-3212.
27. Bahirwani R, Campbell MS, Siropaides T, et al. Transplantation: Impact of